Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Empting

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
ACS Chemical Biology|January 13, 2022
First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer TherapyCharlotte Dahlem, Ali Abuhaliema, Sonja M Kessler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Tracheal brush cells release acetylcholine in response to bitter tastants for paracrine and autocrine signalingMonika I Hollenhorst, Innokentij Jurastow, Rajender Nandigama, et al.
Angewandte Chemie (International Ed. in English)|April 4, 2020
Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm InfectionsDuy-Khiet Ho, Xabier Murgia, Chiara De Rossi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 3, 2023
Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-PrincipleMostafa M Hamed, Ahmed S Abdelsamie, Katharina Rox, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2022
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle StagesSvenja M Sake, Christina Kosch, Sebastian Blockus, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 24, 2021
A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa BiofilmsChristian Schütz, Duy-Khiet Ho, Mostafa Mohamed Hamed, et al.
Nature Communications|February 8, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSvenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, et al.
Nature Reviews. Chemistry|April 28, 2023
Towards the sustainable discovery and development of new antibioticsMarcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Nature Reviews. Chemistry|August 24, 2021
Towards the sustainable discovery and development of new antibioticsMarcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Cell Genomics|May 10, 2025
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethalityChelsea E Cunningham, Frederick S Vizeacoumar, Yue Zhang, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
ACS Chemical Biology|January 13, 2022
First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer TherapyCharlotte Dahlem, Ali Abuhaliema, Sonja M Kessler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Tracheal brush cells release acetylcholine in response to bitter tastants for paracrine and autocrine signalingMonika I Hollenhorst, Innokentij Jurastow, Rajender Nandigama, et al.
Angewandte Chemie (International Ed. in English)|April 4, 2020
Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm InfectionsDuy-Khiet Ho, Xabier Murgia, Chiara De Rossi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 3, 2023
Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-PrincipleMostafa M Hamed, Ahmed S Abdelsamie, Katharina Rox, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2022
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle StagesSvenja M Sake, Christina Kosch, Sebastian Blockus, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 24, 2021
A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa BiofilmsChristian Schütz, Duy-Khiet Ho, Mostafa Mohamed Hamed, et al.
Nature Communications|February 8, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSvenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, et al.
Nature Reviews. Chemistry|April 28, 2023
Towards the sustainable discovery and development of new antibioticsMarcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Nature Reviews. Chemistry|August 24, 2021
Towards the sustainable discovery and development of new antibioticsMarcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Cell Genomics|May 10, 2025
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethalityChelsea E Cunningham, Frederick S Vizeacoumar, Yue Zhang, et al.
Pageof 8